文献

J-GLOBAL ID：202202250886519059   整理番号：22A1215724

多発性骨髄腫患者におけるSARS-CoV-2 mRNA COVID-19ワクチンに対する低い臨床的防御反応

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

著者 (17件)： Terao Toshiki (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Yamashita Takeshi (Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan) ,  Yamashita Takeshi (Division of Internal Medicine, Keiju Kanazawa Hospital, Ishikawa, Japan) ,  Fukumoto Ami (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Kamura Yuya (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Ikeda Daisuke (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Kuzume Ayumi (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Tabata Rikako (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Tsushima Takafumi (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Miura Daisuke (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Narita Kentaro (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Takeuchi Masami (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan) ,  Doi Masahiro (Department of Clinical Laboratory, Kameda Medical Center, Kamogawa, Japan) ,  Umezawa Yuka (Department of Clinical Laboratory, Kameda Medical Center, Kamogawa, Japan) ,  Otsuka Yoshihito (Department of Clinical Laboratory, Kameda Medical Center, Kamogawa, Japan) ,  Takamatsu Hiroyuki (Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan) ,  Matsue Kosei (Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Chiba, Japan)
資料名： International Journal of Hematology  (International Journal of Hematology)
巻： 115  号： 5  ページ： 737-747  発行年： 2022年05月 
JST資料番号： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 要約:形質細胞障害(PCD)患者におけるコロナウイルス疾患2...

シソーラス用語： ヒト ,...
準シソーラス用語： 2019nCoVワクチンmRNA1273 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1215724&from=J-GLOBAL&jstjournalNo=F0888A") }}

著者キーワード (6件)： COVID-19 ,  SARS-CoV-2 ,  mRNAワクチン ,  形質細胞障害 ,  多発性骨髄腫 ,  抗CD38抗体

分類 (4件)： 血液の腫よう  (GK04000M) ,  呼吸器疾患の薬物療法  (GI05020J) ,  感染症・寄生虫症一般  (GD01010H) ,  免疫療法薬・血液製剤の臨床への応用  (GW22020O)

タイトルに関連する用語 (8件)： 多発性骨髄腫 ,  患者 ,  SARS-CoV-2 ,  mRNA ,  COVID-19 ,  ワクチン ,  臨床 ,  防御反応